207 related items for PubMed ID: 11392363
1. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.
J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
[Abstract] [Full Text] [Related]
2. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
3. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.
Adams N, Lasserson TJ, Cates CJ, Jones PW.
Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD002310. PubMed ID: 17943772
[Abstract] [Full Text] [Related]
4. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
Adams N, Bestall JM, Lasserson TJ, Jones PW.
Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002310. PubMed ID: 15846637
[Abstract] [Full Text] [Related]
5. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
Eur Respir J; 1996 Nov 18; 9(11):2263-72. PubMed ID: 8947070
[Abstract] [Full Text] [Related]
6. Fluticasone versus beclomethasone or budesonide for chronic asthma.
Adams N, Bestall JM, Jones PW.
Cochrane Database Syst Rev; 2002 Nov 18; (1):CD002310. PubMed ID: 11869636
[Abstract] [Full Text] [Related]
7. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar 18; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
8. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma.
Adams N, Bestall JM, Lasserson TJ, Jones PW.
Cochrane Database Syst Rev; 2004 Mar 18; (2):CD002310. PubMed ID: 15106173
[Abstract] [Full Text] [Related]
9. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P.
J Pediatr; 1999 Apr 18; 134(4):422-7. PubMed ID: 10190915
[Abstract] [Full Text] [Related]
10. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators.
Respir Med; 2002 Nov 18; 96(11):851-61. PubMed ID: 12418582
[Abstract] [Full Text] [Related]
11. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
Arch Dis Child; 1993 Aug 18; 69(2):206-11. PubMed ID: 8215522
[Abstract] [Full Text] [Related]
12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr 18; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
13. Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate.
Berend N, Kellett B, Kent N, Sly PD, Collaborative Study Group of the Australian Lung Foundation.
Respirology; 2001 Sep 18; 6(3):237-46. PubMed ID: 11555383
[Abstract] [Full Text] [Related]
14. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL.
Eur Respir J; 1993 Jun 18; 6(6):877-85. PubMed ID: 8339809
[Abstract] [Full Text] [Related]
15. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
Ayres JG, Bateman ED, Lundbäck B, Harris TA.
Eur Respir J; 1995 Apr 18; 8(4):579-86. PubMed ID: 7664857
[Abstract] [Full Text] [Related]
16. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
Agertoft L, Pedersen S.
J Allergy Clin Immunol; 1997 Jun 18; 99(6 Pt 1):773-80. PubMed ID: 9215245
[Abstract] [Full Text] [Related]
17. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.
Rutherford C, Mills R, Gibson PG, Price MJ.
Respirology; 2003 Sep 18; 8(3):371-5. PubMed ID: 12911833
[Abstract] [Full Text] [Related]
18. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A.
Eur Respir J; 1994 Dec 18; 7(12):2179-84. PubMed ID: 7713201
[Abstract] [Full Text] [Related]
19. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I.
Allergol Immunopathol (Madr); 1999 Dec 18; 27(6):298-303. PubMed ID: 10611554
[Abstract] [Full Text] [Related]
20. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H, Yamase H.
Arerugi; 2003 Jan 18; 52(1):31-8. PubMed ID: 12598720
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]